Zobrazeno 1 - 10
of 19
pro vyhledávání: '"A V Sozykin"'
Spontaneous reperfusion of infact-related artery in patients with ST elevation myocardial infarction
Autor:
M Ya Ruda, A I Kuz'min, I N Merkulova, A N Samko, E V Merkulov, A V Sozykin, D U Akasheva, A I Kuzmin
Publikováno v:
Терапевтический архив, Vol 81, Iss 5, Pp 20-29 (2009)
Aim. To characterize a clinical course of ST elevation myocardial infarction (STEMI) and spontaneous reperfusion of the coronary arteries (SR) as well as in patients after reperfusion trombolytic therapy (TLT) and/or transluminal ballon coronary angi
Externí odkaz:
https://doaj.org/article/86a12e46072147138a1c4962d9fd493d
Autor:
A N Samko, I V Pershukov, Т A Batyraliev, Z A Niyazova-Karben, О Calenici, A Karaus, N Guler, В Eryonucu, S Kadayifci, A Temamogullari, S Ozgul, F Akgul, I V Levitsky, A V Sozykin, F Besnili, F Arful, Sh Т Jamgyrchiev, A Sercelik, H Sengul, B S Daniyarov, O Demirbas, Yu N Belenkov
Publikováno v:
Терапевтический архив, Vol 78, Iss 4, Pp 47-51 (2003)
Aim. An open non-randomized trial was initiated to assess clinical and angiographic results of using the coronary stent "Ephesos" in 457patients with stable or unstable angina pectoris and native coronary affections. Material and methods. 268 stents
Externí odkaz:
https://doaj.org/article/030a0ee12f8546bab5584e0fa85f21ff
Autor:
Amina M. Alieva, Aleksei V. Butenko, Natalia V. Teplova, Elena V. Reznik, Ramiz K. Valiev, Elina А. Skripnichenko, Aleksei V. Sozykin, Igor G. Nikitin
Publikováno v:
Consilium Medicum, Vol 24, Iss 12, Pp 882-887 (2023)
Currently, the search and study of new biological markers that can provide early diagnosis of cardiovascular diseases, serve as a laboratory tool for assessing the effectiveness of treatment, or be used as prognostic markers and risk stratification c
Externí odkaz:
https://doaj.org/article/0e92f45d2180484ba8fb1c7c77141731
Autor:
A. M. Alieva, A. V. Sozykin, N. V. Teplova, E. V. Reznik, D. V. Izimarieva, N. A. Novikova, I. V. Lozovsky, Е. E. Averin, R. K. Valiev, I. G. Nikitin
Publikováno v:
Российский кардиологический журнал, Vol 27, Iss 8 (2022)
Novel biological markers, such as fibrosis marker galectin-3, peptide hormone adrenomedullin, soluble ST2, chemokine CX3CL1, surrogate marker of vasopressin, and others, are every year one step closer to being introduced into health practice. Over th
Externí odkaz:
https://doaj.org/article/c8cd7323053049a1b259f02dd0fea57f
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 16, Iss 1, Pp 33-39 (2020)
Aim. To study the effects of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor, alirocumab, on lipid levels in patients who receive secondary prevention of cardiovascular diseases (CVD) and require enhanced lipid-lowering therapy.Materi
Externí odkaz:
https://doaj.org/article/0204f048f1134c66a2d43aad9109bfdc
Autor:
A. D. Kudryavtsev, A. V. Sozykin, A. E. Nikitin, I. A. Znamenskiy, A. K. Kondakov, A. L. Yudin, S. A. Korvyakov
Publikováno v:
Medical Radiology and radiation safety. 66:63-68
Purpose: To determine the role of nuclear medicine methods in the diagnosis and quality control of treatment and rehabilitation of patients with complications after coronavirus diseasr (COVID-19) The article provides a brief analysis of the incidence
Autor:
Aleksei E. Nikitin, Viktor V. Diachenko, Evgenii E. Averin, Aleksei V. Sozykin, Aleksandr A. Melnikov, Igor V. Shubin
Publikováno v:
Consilium Medicum. 23:372-381
The review provides the literature data on the basal issues of bone remodeling and the applied use of medical imaging techniques for the prevention of clinically significant consequences of osteoporosis. The article discusses the role and prospects o
Autor:
O. G. Kompaniets, M. R. Dudarenkova, M. L. Ginzburg, S. I. Davydov, A. O. Pozdnyak, E. G. Martemyanova, I. L. Fridman, V. S. Zhuk, M. A. El Sharif, E. L. Fedorova, E. E. Averin, A. V. Sozykin, N. V. Kirpichnikova, A. E. Nikitin
Publikováno v:
Kardiologiia. 60:155-164
The article analyzes properties of potassium and magnesium, which may exert vasodilatory, anti-inflammatory, anti-ischemic, antiaggregant, and antiarrhythmic effects. These are extremely important microelements and potentially beneficial therapeutic
Autor:
A. V. Sozykin, O. P. Shevchenko, Ya. A. Naumov, A. G. Strokov, V. P. Vasilieva, A. O. Shevchenko
Publikováno v:
Vestnik Transplantologii i Iskusstvennyh Organov, Vol 21, Iss 4, Pp 121-128 (2020)
Currently, kidney transplantation and hemodialysis are the primary therapies for end-stage renal disease. High mortality, mostly caused by cardiovascular disease, remains the main challenge in the treatment of this category of patients. It has been s
Publikováno v:
Медицинский совет, Vol 0, Iss 21, Pp 34-41 (2019)
Updates of clinical guidelines and publication of new research results entail changes in our approaches to diagnosing diseases and treating patients, as well as revising the criteria for choosing a particular drug to a specific patient. We are based